Aktuella utlysningar, vecka 46, 2018
Grants Office tipsar om aktuella utlysningar
Svenska och nordiska utlysningar
Nordic Trial Alliance, proposals for strategic workshops – NordForsk
NordForsk, through the Nordic Trial Alliance, invites proposals for strategic workshops. These grants support the organisation of strategic workshops or networking activities to promote Nordic cooperation within clinical research. Activities using real-world data to support the development and implementation of personalised medicine are particularly encouraged. Representatives of Nordic research organisations, public sector, patient organisations or other relevant organisations may apply. Companies may not receive funding, but they may take part in activities at their own cost. Grants are worth up to NOK 300,000.
Closing date: 7 December 2018
Forskningsstipendier inom urologi, barnsjukdommar och ekonomisk journalism – Maud & Birger Gustavsson Foundations
Maud & Birger Gustavssons Stiftelser inbjuder ansökningar om stipendier. Dessa stöder forskning och utbildning inom olika områden av medicin, i första hand inom urologisk kirurgi, samt utvecklingsarbete för att förebygga och lindra sjukdom bland barn i utvecklingsländer.
Closing date: 7 December 2018
Open announcement for additional national NBIS services
For the future development of NBIS, we hereby invite proposals for additional bioinformatics services that would be valuable for the national life science community. These will be funded for up to two years with possible extension. The service could be expertise or infrastructure component(s) or a combination of both. Examples of areas from previous open announcements are proteomics, phylogenomics, and protein structure prediction servers.
Closing date: 12 December 2018
Travel grants – Lennart Kenne's Memorial Fund
The Fund distributes two travel grants annually to PhD students or postdocs working on projects within natural product chemistry, mainly focused on structure determination. Travel grants will serve as support for participation in conferences where the beneficiary has the opportunity to present their research orally and / or as a poster. The size of the travel grant awarded is normally between 10 000 and 20 000 SEK.
Closing date: 15 December 2018
Bidrag för hjärnforskning – Märta Lundqvist Foundation
Märta Lundqvists Stiftelse inbjuder ansökningar om bidrag för hjärnforskning. Dessa stöder forskning vid svenska universitet som är relaterad till den mänskliga hjärnans område. Prioritet ges till patientrelaterad och kliniskt fokuserad forskning. Forskare vid svenska universitet med avlagd doktorsexamen efter 1 januari 2014 kan söka. Bidrag uppgår till SEK 1.49 miljoner.
Closing date: 11 January 2019
Forskningsbidrag – Stiftelsen Längmanska kulturfonden
Stiftelsen Längmanska kulturfonden inbjuder ansökningar om forskningsbidrag. Dessa främjar humanistiska vetenskaper, naturvetenskaper, konst och litteratur samt folkbildningsverksamhet. Behöriga att söka är enskilda personer och organisationer. Bidrag ges inte till finansiering av egen utbildning. Bidragen är vanligtvis värda mellan SEK 15,000 och SEK 50,000.
Closing date: 15 January 2019
Medel till forsknings- och utvecklingsprojekt – Sveriges Dövas Riksförbunds Testaments- och Donationsstiftelse
Sveriges Dövas Riksförbunds Testaments- och Donationsstiftelse inbjuder ansökningar om medel till forsknings- och utvecklingsprojekt. Dessa syftar till att förbättra dövas delaktighet i samhället och öka samverkan, närhet och kunskapsförmedling mellan dövrörelsen, institutioner, organisationer och myndigheter som på olika sätt är berörda av arbetet kring dövfrågor.
Closing date: 1 February 2019
Short-term Eurolife Research Exchanges 4th round 2018
Researchers at KI are invited to apply for short-term research exchange grants funded by Eurolife. The goal of this call is to facilitate further research collaboration between Eurolife member institutions. The grant on 1500 EUR will support travel and living expenses for junior scientists to travel to another Eurolife institution and perform research for a period equal to or longer than 2 weeks during the period 1 March – 31 December 2019.
Closing date: 21 December 2018.
ERC Consolidator Grant: ERC-2019-CoG
ERC Consolidator Grants are designed to support excellent Principal Investigators at the career stage at which they may still be consolidating their own independent research team or programme. Applicants should have been awarded their first PhD > 7 and ≤ 12 years prior to 1 January 2019, with exceptions for parental leave, national service, clinical training and long-term illness.
Closing date: The ERC-2019-CoG call is now open and will close on February 7th 2019. Further information can be found here:
Eppendorf award for young European investigators - Eppendorf AG
The Eppendorf AG, in partnership with the scientific journal Nature, invites applications for its award for young European investigators. This recognises contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.
European researchers, no older than 35 years, who hold a PhD or MD, performing biomedical research in Europe based on methods of molecular biology, including novel analytical concepts, may apply. The award consists of €20,000 plus coverage of the prize winner’s work by Nature in print and online
Closing date: 15 January 2019
Research grants - Cure Parkinson’s Trust
The Cure Parkinson’s Trust invites applications for its research grants. These support laboratory or clinical research projects that have the potential to advance knowledge that might lead to a cure for Parkinson’s disease. Applications must be for research that slows, stops or reverses the disease and translates into clinical phase 2b trials within five years.
Scientists or clinicians based in an accredited university or hospital worldwide, or commercial organisations, may apply. Grants are usually worth between £50,000 to £250,000 each over a period of one to three years.
Closing date: 24 January 2019
Clinical research award Bayer
The European Foundation for the Study of Diabetes and Novo Nordisk invite applications for their diabetes research in Europe programme. This supports initiatives in all areas of diabetes research in order to rapidly diffuse acquired knowledge and to facilitate its application. Funding is available for both basic and clinical research.
Applications are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be employed at a non-profit institution and the study must be performed at their place of work. Grants are worth up to €100,000 for basic research projects and up to €400,000 for clinical research projects.
Closing date: 1 Febrary 2019
Federal Funding agencies
Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed): NIH
The purpose of this funding opportunity announcement (FOA) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads towards clinical trials. Applicants must have a promising hit/lead, robust biological rationale for the intended approach, and identified assays for optimization of the agent. The scope of this program includes optimization and early development activities, IND-enabling studies, and assembly of Investigational New Drug (IND) application. This is a milestone-driven phased cooperative agreement program involving participation of NIH program staff in the development of the project plan and monitoring of research progress.
Closing date: January 4, 2019 and March 6, 2019, by 5:00PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-NS-19-010
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional): NIH
The purpose of this funding opportunity announcement (FOA) is to encourage research that will improve and increase the use of evidence-based interventions in end-of-life and palliative care (EOLPC) for American Indian/Alaska Native (AI/AN) individuals with advanced illness and their families and communities.
Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-19-057 (R01); PAR-19-058 (R21).
Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional): NIH
This Funding Opportunity Announcement (FOA) supports planning, design and initial pilots for locally relevant and catalytic research on non-communicable diseases (NCDs) or injury in low and middle-income countries (LMICs). Research addressing multiple NCDs and their risk factors and research addressing NCDs as comorbidities for/with infectious diseases including HIV/AIDS is encouraged. Only scientists from the LMIC institutions are eligible to apply as the contact PI/PD.
Research activities under this FOA are expected to inform the development of comprehensive research programs that contribute to the long-term goals of building sustainable research capacity in LMICs to address NCDs and injury throughout life and to lead to diagnostics, prevention, treatment and implementation strategies. The proposed work may also contribute to developing a base for research networking and evidence-based policy beyond the specific research project. For applications on any research topic related to the brain, nervous system, mental health and substance abuse please see the companion FOA: PAR-18-836 "Global Brain and Nervous System Disorders Research Across the Lifespan (R21)". Applications on those topics are not appropriate for this FOA.
Closing date: December 13, 2018, December 13, 2019, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-19-059
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional): NIH
The purpose of this Funding Opportunity Announcement (FOA) is to develop and test strategies to increase the engagement of men in HIV prevention and care within global settings and among US domestic populations who have evidenced lower rates of engagement and retention in HIV prevention and care. The R01 mechanism is intended to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies.
Closing date: The first application due date for this FOA is January 7, 2019. Standard AIDS dates apply, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PA-19-042 (R01); PA-19-050 (R21).
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional): NIH
The purpose of this funding opportunity announcement (FOA) is to stimulate research to examine the multi-dimensional foundations, experiences and management of complex, advanced signs and symptoms at the end of life.
Closing date: The first standard application due date for this FOA is February 5, 2019. Standard dates apply, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-19-045 (R01); PAR-19-044 (R21).
2019 Research Award request for applications (RFA), Simons Foundation Autism Research Initiative (SFARI), US
Grants awarded through this program are intended to provide support for the investigation of key unresolved research questions in autism, particularly those that connect etiologies to brain function and behavior. Unlike SFARI Pilot Awards, risk and novelty are welcome but are not required criteria for the proposal to be considered meritorious. Competitive applications will have preliminary data or other relevant groundwork that justifies substantial investment on the proposed topic.
Closing date: January 11, 5:00 p.m. EST, 2019